The 6th TCR-based Therapies Summit returns as the only forum created solely for TCR experts pioneering best-in-class cell- and biologic-based approaches, to dive into T-cell receptor biology and ...

Dr Martin Makary at Senate HELP Committee nomination hearing. Johns Hopkins surgeon and writer Dr Martin Makary, President Donald Trump's pick to lead the FDA, faced a grilling today by the Senate ...

In recognition of Rare Disease Day, Dr Kamran Iqbal, head of medical affairs and patient advocacy in global rare diseases at Chiesi UK, discussed with pharmaphorum the company’s evolving role in ...

Medical, legal and regulatory review (MLR review) of promotional as well as non-promotional materials is one of the core responsibilities of medical and commercial teams within any life sciences ...

Eli Lilly has stepped up its campaign to encourage people to use its weight-loss drug Zepbound over copycat drugs from other sources, such as compounding pharmacies. The drugmaker used a 30-second ...

AbbVie has joined the ranks of pharma groups trying to develop weight-loss drugs, licensing a long-acting amylin analogue from Denmark's Gubra in a deal valued at more than $2.2 billion.

Buoyed by advancements in formulation technologies such as permeation enhancers, nanoparticle encapsulation and structural modification abilities, oral delivery and bioavailability of peptide ...

Investors looking for a quick turnaround in the fortunes of Bayer are likely to be disappointed by chief executive Bill Anderson's assessment of the next couple of years as he delivers the group's ...

All this results in what Joe Daley, president of Addison Whitney, the global branding agency that named Ozempic and Wegovy, ...

The Innovation in Psychosis Therapeutics Summit is the leading industry event driving the next generation of psychosis drug ...

At the JP Morgan Healthcare Conference in January, pharmaphorum editor-in-chief Jonah Comstock caught up with Bradley Bostic, the co-founder, CEO, president, and chairman of h1c to talk about one such ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...